US funding for biodefense research continues on an upward trend, but some say the effort is misguided. Laura DeFrancesco reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


References
Koizumi, K. Research Holds, Development Gains in 2005 Budget. AAAS Analysis of R&D in the FY 2005 Budget (American Association for the Advancement of Science, Washington, DC, 5 March 2004).
Koizumi, K. Congressional Action on Research and Development in the FY 2004 Budget (American Association for the Advancement of Science, Washington, DC, USA, 2004).
Williams, M. The looming threat. Acumen J. Sci. 1, 40–50 (2003).
Medical Follow-up Agency, Institute of Medicine, Board of Life Sciences. Giving Full Measure to Countermeasures: Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents (National Academies Press, Washington, DC, USA, 2004).
Burrill, G.S. Biotech 2003. Life Sciences: Reevaluation and Restructuring (Burrill & Company, San Francisco, USA, 2003).
Fox, J.L. US budget emphasizes bioterrorism countermeasures. Nat. Biotechnol. 22, 256–257 (2004).
Moser Jones, M. Say anthrax, or who got what in NIH FY 2003 grants for biodefense and category A pathogens. GenomeWeb News, 24 October 2003 (http://www.genomeweb.com/).
Schmitt, B. Research for a Secure Europe. GOP Draft (EU Institute for Security Studies, Paris, 2 February 2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFrancesco, L. Throwing money at biodefense. Nat Biotechnol 22, 375–378 (2004). https://doi.org/10.1038/nbt0404-375
Issue date:
DOI: https://doi.org/10.1038/nbt0404-375